|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02348 DAWNRAYS PHARMA
Nominal 
1.080 -0.050 (-4.425%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | -- | -- | 2,611 | 2,739 | 0 | 0 |
| Property, plant, equip. & others | -- | -- | 1,123,763 | 1,115,805 | 1,191,266 | 1,032,131 |
| Land & other Lease Assets | -- | -- | 104,644 | 101,456 | 109,603 | 110,755 |
| Intangible Assets | -- | -- | 542,081 | 529,465 | 536,185 | 528,171 |
| Interests in Asso. & JCEs | -- | -- | 0 | 0 | 25,345 | 87,250 |
| Other Non-current Assets | -- | -- | 33,936 | 152,998 | 66,249 | 70,215 |
| -- | -- | 1,807,035 | 1,902,463 | 1,928,648 | 1,828,522 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | -- | -- | 308,241 | 211,107 | 241,746 | 203,476 | |
| Trade Receivables | -- | -- | 267,886 | 321,996 | 402,850 | 346,778 | |
| Cash & Bank Balances | -- | -- | 615,675 | 366,826 | 811,682 | 577,744 | |
| Other Current Assets | -- | -- | 999,436 | 820,267 | 285,139 | 288,775 | |
| Assets Held for Sale | -- | -- | 11,003 | 0 | 2,578 | 94,263 | |
| -- | -- | 2,202,241 | 1,720,196 | 1,743,995 | 1,511,036 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | -- | -- | 221,560 | 162,161 | 224,073 | 143,212 | ||
| S-T Debt & Leases | -- | -- | 31,024 | 120,424 | 7,968 | 21,993 | ||
| Other Current Liabilities | -- | -- | 302,019 | 386,355 | 700,016 | 531,899 | ||
| Liab asso w/ Assets Held for Sale | -- | -- | 0 | 0 | 0 | 0 | ||
| -- | -- | 554,603 | 668,940 | 932,057 | 697,104 | |||
| Net Current Assets | -- | -- | 1,647,638 | 1,051,256 | 811,938 | 813,932 | ||
| Total Assets Less Current Liabilities | -- | -- | 3,454,673 | 2,953,719 | 2,740,586 | 2,642,454 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | -- | -- | 3,695 | 103 | 444 | 1,527 | |||
| Other Non-current Liabilities | -- | -- | 124,310 | 94,382 | 90,275 | 243,066 | |||
| -- | -- | 128,005 | 94,485 | 90,719 | 244,593 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | -- | -- | 80,530 | 80,455 | 80,389 | 80,370 | ||||
| Reserves | -- | -- | 3,243,738 | 2,774,201 | 2,561,567 | 2,300,344 | ||||
| Others | -- | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | -- | -- | 3,324,268 | 2,854,656 | 2,641,956 | 2,380,714 | ||||
| Non-controlling Interests | -- | -- | 2,400 | 4,578 | 7,911 | 17,147 | ||||
| Others | -- | -- | 0 | 0 | 0 | 0 | ||||
| -- | -- | 3,326,668 | 2,859,234 | 2,649,867 | 2,397,861 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 21,519 | 62,588 | 111,303 | 239,908 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 30/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 213,971 |
| %Change | -62.125% |
| EPS / (LPS) | RMB 0.140 |
| NBV Per Share (¥) | RMB -- |